PubMed:9882624
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 16-40 | protein | denotes | low-density lipoproteins |
| T2 | 70-83 | protein | denotes | interleukin 2 |
| T3 | 88-109 | protein | denotes | nuclear factor kappaB |
| T4 | 128-151 | cell_type | denotes | activated T-lymphocytes |
| T5 | 268-292 | protein | denotes | low-density lipoproteins |
| T6 | 294-300 | protein | denotes | oxLDLs |
| T7 | 409-415 | protein | denotes | oxLDLs |
| T8 | 433-460 | protein | denotes | interleukin (IL)-2-receptor |
| T9 | 592-598 | protein | denotes | oxLDLs |
| T10 | 628-632 | protein | denotes | IL-2 |
| T11 | 672-693 | protein | denotes | nuclear factor kappaB |
| T12 | 695-704 | protein | denotes | NF-kappaB |
| T13 | 746-752 | protein | denotes | oxLDLs |
| T14 | 803-815 | cell_type | denotes | lymphoblasts |
| T15 | 900-911 | cell_type | denotes | lymphocytes |
| T16 | 915-934 | protein | denotes | phytohaemagglutinin |
| T17 | 972-976 | protein | denotes | IL-2 |
| T18 | 1008-1011 | protein | denotes | CD3 |
| T19 | 1102-1111 | protein | denotes | NF-kappaB |
| T20 | 1124-1130 | protein | denotes | oxLDLs |
| T21 | 1152-1178 | protein | denotes | activation-induced p65/p50 |
| T22 | 1179-1188 | protein | denotes | NF-kappaB |
| T23 | 1274-1283 | protein | denotes | p50 dimer |
| T24 | 1369-1396 | protein | denotes | cytosolic inhibitor protein |
| T25 | 1397-1410 | protein | denotes | IkappaB-alpha |
| T26 | 1492-1498 | protein | denotes | oxLDLs |
| T27 | 1540-1552 | cell_type | denotes | T-lymphocyte |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-152 | Sentence | denotes | Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes. |
| S2 | 153-258 | Sentence | denotes | Activated T-lymphocytes are found early in atherosclerosis lesions, but little is known about their role. |
| S3 | 259-552 | Sentence | denotes | Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor expression on the surface of in vitro-activated T-lymphocytes but also their proliferation. |
| S4 | 553-738 | Sentence | denotes | We have now investigated the effect of oxLDLs on blast differentiation, on IL-2 synthesis and on the activation of the nuclear factor kappaB (NF-kappaB) system in activated lymphocytes. |
| S5 | 739-953 | Sentence | denotes | Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants after activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin. |
| S6 | 954-1088 | Sentence | denotes | The inhibition of IL-2 production was observed in the CD3(+) T-lymphocyte cytoplasm as early as 4 h after activation by PMA+ionomycin. |
| S7 | 1089-1298 | Sentence | denotes | The study of NF-kappaB showed that oxLDLs led to a decrease of activation-induced p65/p50 NF-kappaB heterodimer binding to DNA, whereas the presence of the constitutive nuclear form of p50 dimer was unchanged. |
| S8 | 1299-1411 | Sentence | denotes | This was correlated with an unchanged level of the active form of the cytosolic inhibitor protein IkappaB-alpha. |
| S9 | 1412-1575 | Sentence | denotes | Taken together, these observations suggest that the immunosuppressive effect of oxLDLs might operate via a dysregulation of the T-lymphocyte activation mechanisms. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 121-124 | NP | denotes | DNA |
| C2 | 128-151 | NP | denotes | activated T-lymphocytes |
| C3 | 153-176 | NP | denotes | Activated T-lymphocytes |
| C4 | 196-219 | NP | denotes | atherosclerosis lesions |
| C5 | 247-252 | NP | denotes | their |
| C6 | 259-301 | NP | denotes | Oxidized low-density lipoproteins (oxLDLs) |
| C7 | 355-366 | NP | denotes | the lesions |
| C8 | 409-415 | NP | denotes | oxLDLs |
| C9 | 433-471 | NP | denotes | interleukin (IL)-2-receptor expression |
| C10 | 532-537 | NP | denotes | their |
| C11 | 592-598 | NP | denotes | oxLDLs |
| C12 | 716-737 | NP | denotes | activated lymphocytes |
| C13 | 939-952 | NP | denotes | PMA+ionomycin |
| C14 | 1074-1087 | NP | denotes | PMA+ionomycin |
| C15 | 1124-1130 | NP | denotes | oxLDLs |
| C16 | 1212-1215 | NP | denotes | DNA |
| C17 | 1492-1498 | NP | denotes | oxLDLs |
| R1 | C3 | C2 | coref-ident | Activated T-lymphocytes,activated T-lymphocytes |
| R2 | C5 | C3 | coref-pron | their,Activated T-lymphocytes |
| R3 | C7 | C4 | coref-ident | the lesions,atherosclerosis lesions |
| R4 | C8 | C6 | coref-ident | oxLDLs,Oxidized low-density lipoproteins (oxLDLs) |
| R5 | C10 | C9 | coref-pron | their,interleukin (IL)-2-receptor expression |
| R6 | C11 | C8 | coref-ident | oxLDLs,oxLDLs |
| R7 | C12 | C3 | coref-ident | activated lymphocytes,Activated T-lymphocytes |
| R8 | C14 | C13 | coref-ident | PMA+ionomycin,PMA+ionomycin |
| R9 | C15 | C11 | coref-ident | oxLDLs,oxLDLs |
| R10 | C16 | C1 | coref-ident | DNA,DNA |
| R11 | C17 | C15 | coref-ident | oxLDLs,oxLDLs |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 16-40 | protein_family_or_group | denotes | low-density lipoproteins |
| T2 | 70-83 | protein_molecule | denotes | interleukin 2 |
| T3 | 88-109 | protein_complex | denotes | nuclear factor kappaB |
| T4 | 128-151 | cell_type | denotes | activated T-lymphocytes |
| T5 | 196-219 | tissue | denotes | atherosclerosis lesions |
| T6 | 268-292 | protein_family_or_group | denotes | low-density lipoproteins |
| T7 | 294-300 | protein_family_or_group | denotes | oxLDLs |
| T8 | 409-415 | protein_family_or_group | denotes | oxLDLs |
| T9 | 433-460 | protein_molecule | denotes | interleukin (IL)-2-receptor |
| T10 | 592-598 | protein_family_or_group | denotes | oxLDLs |
| T11 | 602-623 | other_name | denotes | blast differentiation |
| T12 | 628-632 | protein_molecule | denotes | IL-2 |
| T13 | 672-693 | protein_complex | denotes | nuclear factor kappaB |
| T14 | 695-704 | protein_complex | denotes | NF-kappaB |
| T15 | 746-752 | protein_family_or_group | denotes | oxLDLs |
| T16 | 803-815 | cell_type | denotes | lymphoblasts |
| T17 | 900-911 | cell_type | denotes | lymphocytes |
| T18 | 915-934 | protein_molecule | denotes | phytohaemagglutinin |
| T19 | 939-943 | other_organic_compound | denotes | PMA+ |
| T20 | 943-952 | other_organic_compound | denotes | ionomycin |
| T21 | 972-976 | protein_molecule | denotes | IL-2 |
| T22 | 1008-1011 | protein_molecule | denotes | CD3 |
| T23 | 1074-1078 | other_organic_compound | denotes | PMA+ |
| T24 | 1078-1087 | other_organic_compound | denotes | ionomycin |
| T25 | 1102-1111 | protein_complex | denotes | NF-kappaB |
| T26 | 1124-1130 | protein_family_or_group | denotes | oxLDLs |
| T27 | 1152-1175 | protein_complex | denotes | activation-induced p65/ |
| T28 | 1175-1178 | protein_subunit | denotes | p50 |
| T29 | 1179-1188 | protein_complex | denotes | NF-kappaB |
| T30 | 1274-1277 | protein_subunit | denotes | p50 |
| T31 | 1369-1396 | protein_family_or_group | denotes | cytosolic inhibitor protein |
| T32 | 1397-1410 | protein_molecule | denotes | IkappaB-alpha |
| T33 | 1492-1498 | protein_family_or_group | denotes | oxLDLs |
| T34 | 1519-1532 | other_name | denotes | dysregulation |
| T35 | 1540-1552 | cell_type | denotes | T-lymphocyte |